When was ABclonal Biotechnology founded?

ABclonal Biotechnology was founded in 2006 and raised its 1st funding round 14 years after it was founded.

Where is ABclonal Biotechnology located?

ABclonal Biotechnology is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts.

Who is the current CEO of ABclonal Biotechnology?

Kyle Ma of ABclonal Biotechnology.

How many employees does ABclonal Biotechnology have?

As of Jul 31, 2026, the latest employee count at ABclonal Biotechnology is 100.

Is ABclonal Biotechnology a funded company?

ABclonal Biotechnology is a funded company, having raised a total of $281M across 2 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on 2020.

When was the latest funding round of ABclonal Biotechnology?

ABclonal Biotechnology's latest funding was a $***** Series D round on Dec 08, 2021, with participation from 5 investors. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.23B in funding in 2026 to date.

Where does ABclonal Biotechnology rank among its competitors?

ABclonal Biotechnology ranks 29th amongst 918 active competitors, of which 47 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of ABclonal Biotechnology?

ABclonal Biotechnology's top competitors include Abcam, Meridian Bioscience and Enzo. Among them, BioLamina secured the most recent funding round in April, 2026.

ABclonal Biotechnology - 2026 Company Profile, Team, Funding & Competitors

ABclonal Biotechnology is a series D company based in Woburn (United States), founded in 2006. It operates as a Developer of protein and peptide reagents and kits for cell and molecular biology research. ABclonal Biotechnology has raised $281M in funding from investors like Sequoia Capital, C&D and Sequoia Capital China. The company has 918 active competitors, including 47 funded and 96 that have exited. Its top competitors include companies like Abcam, Meridian Bioscience and Enzo.

Company Details

ABclonal Biotechnology manufactures protein reagents and kits for cell and molecular biology research. The company's products include a wide range of monoclonal, polyclonal, native or modified primary as well as tagged secondary antibodies, catalog and custom recombinant proteins, ELISA kits and gene clones. The company also provides peptide synthesis, peptide libraries, peptide modification, GMP peptide, glycopeptide and PNA services, custom antibody development, and protein expression services in bacterial, insect, yeast or mammalian cells.

Website: abclonal.com
Social
Email ID: *****@abclonal.com
Phone Number: +1 **********, +1 **********
Part Of
Registered Address: Woburn, Massachusetts

Key Metrics

Founded Year

2006

Location

Woburn, United States

Stage

Series D

Total Funding

$281M in 2 rounds

Latest Funding Round

Series D, Dec 08, 2021, $*****

Investors

Sequoia Capital & 10 more

Ranked

29^th among 918 active competitors

Employee Count

100 as on Jul 31, 2026

Similar Companies

Abcam & 1056 more

View ABclonal Biotechnology's full profile

ABclonal Biotechnology is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ABCLONAL UK LIMITED CIN: 13740530 , United Kingdom, Active	Nov 11, 2021	£0 - £1M (As on Dec 31, 2022)	1 (As on Dec 31, 2024)
ABCLONAL SCIENCE INC CIN: 814208496 , United States, Active	Dec 31, 1999	-	30 (As on Dec 31, 2024)	-

ABclonal Biotechnology has raised a total funding of $281M over 2 rounds. Its first funding round was on 2020. Its latest funding round was a Series D round on Dec 08, 2021 for $*****. 5 investors participated in its latest round. ABclonal Biotechnology has 11 institutional investors.

Here is the list of recent funding rounds of ABclonal Biotechnology:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 08, 2021	7119473	Series D	4537159	7388953	8913170	8809039
2020	7701	Series C	8249	1923	Sequoia Capital & 2 more	Sigma Square Capital

Access funding benchmarks and valuations. Sign up today!

View details of ABclonal Biotechnology's funding rounds and investors

ABclonal Biotechnology's employee count trend

ABclonal Biotechnology has 100 employees as of Jul 26. Here is ABclonal Biotechnology's employee count trend over the years:

Employee count trend for ABclonal Biotechnology

Uncover ABclonal Biotechnology's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ABclonal Biotechnology include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of ABclonal Biotechnology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
4th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
5th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
6th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
7th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 1 others	56/100
8th	PL BioScience 2015, Aachen (Germany), Series A	Manufacturer of human platelet lysate products for cell culture applications	$13M	TechVision Fonds, Brightlands Venture Partners ... & 18 others	55/100
9th	Luminex 1995, Austin (United States), Acquired	Developer of instruments, reagents and kits for clinical diagnostics and life science research	-	Public Health Emergency, National Science Foundation ... & 1 others	55/100
10th	Firefly BioWorks 2009, Cambridge (United States), Acquired	Develops platform to allow multiplexed assays on standard laboratory instrumentation	$3.77M	PBM Capital, Breton Capital Ventures & 3 others	54/100
29th	ABclonal Biotechnology 2006, Woburn (United States), Series D	Developer of protein and peptide reagents and kits for cell and molecular biology research	$281M	Loayal Valley Capital, LYFE Capital & 9 others	43/100